Please find all related articles below.
The European Commission has published its draft proposal to revise the Clinical Trial Directive.
According to the European Commission, the main aim of the revised proposal is to simplify the rules for conducting clinical trials in Europe, while maintaining the highest standards of patient safety.
Once adopted, the proposed Regulation will replace the 2001 ’Clinical Trials Directive’. The objective is to ensure that Clinical Trials rules are identical throughout the EU.
Along with the European Commission, Ashoka (the worlds’ oldest and biggest network of social entrepreneurs) and Generali Future Fund present the award ‘European Social Entrepreneur of Active Ageing and Solidarity Between Generations’.
The award recognises individuals who have developed exceptional models to solve a social problem regarding active aging and solidarity between generations. The models should be replicable elsewhere and have the potential to improve (...)
EPHA released its position on Horizon 2020. This document is a result, jointly with its members, to provide the public health opinion in light of the negotiations on Horizon 2020 programme. EPHA welcomes public health priorities recommended by the European Commission. The public health community encourages EU and national decision makers to support the health theme, efforts to promote coordination and access to data.
EPHA Position on Horizon 2020
In a different approach to Innovation, (...)
Health literacy is vital to active and informed healthcare issues and is identified as a key action to reduce health inequalities within the European Union. In this context the European Centre for Disease Prevention and Control (ECDC) has published a paper providing rapid review of the evidence on the effectiveness of interventions to improve health literacy.
The ECDC report focuses on communicable diseases and interventions for disadvantaged populations within the European region. The (...)
The latest (65th) World Health Assembly gathered on 26 May adopted 21 resolutions on a broad range of health issues including: early marriages and pregnancies, the International Health Regulations, mass gatherings, the Millennium Development Goals, non communicable diseases, pandemic influenza preparedness, intensification of the global polio eradication initiative, research and development, nutrition, the social determinants of health and substandard/spurious/falsely (...)
Despite its initial ambition to seek solutions in market-driven innovation and research in accessing to safe, clean and affordable water and sanitation, the European Commission proposal (released last 14 May 2012) on the European Innovation Partnership (EIP) on Water only strengthens a vision of water as a commodity and not as a public good. EPHA evaluates the proposal Against the background of its support to the European Citizens’ Initiative Right to Water.
Read the Commission (...)
The second Flu Summit organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place on 23 March 2012. The event explored new concepts and ideas for bringing together all stakeholders in the fight against flu - both seasonal and pandemic.
Taking off where the ESWI’s First Flu Summit wound up a year ago, the event once again brought together researchers and academics, policy-makers, NGOs, health professionals and industry representatives to debate a (...)
The Health Action International (HAI) Europe (1), and the Trans-Atlantic Consumer Dialogue (2) are co-ordinating a lunch debate on the subject of “Opening up medical research data for an ethical and efficient EU policy.”
The debate will feature Prof. Dr. Wolf-Dieter Ludwig, Chairman at the Drug Commission of the German Medical Association, and Dr. Peter G°tzsche, Director of the Nordic Cochrane Centre as well as responses from the European Commission, the European Ombudsman and (...)
On 15 May 2012, EPHA co-organised an event in collaboration with our member the European Society of Intensive Care Medicine (ESICM) at the European Parliament. Cristian Buşoi MEP (ALDE, Romania) hosted and moderated a policy debate on the contribution of ’’intensivists’’ to better patient outcomes and health systems, tied to the launch of a two-day exhibition to promote the ESCIM’s LIFE-PRIORITY campaign.
The overall aim of the policy debate, entitled (...)
The European Medicines Agency (EMA) has published the final reflection paper on ethical and good clinical practice aspects of clinical trials of medicinal products for human use. Conducted outside of the EU/EEA and submitted in marketing authorisation, it produced several applications to the EU regulatory authorities.
Entering into force on 1 May 2012, the EMA reflection paper aims to strengthen existing processes to provide assurance to regulators and stakeholders that clinical trials (...)